Advertisement

Abstract

Sarkomycin (sarcomycin) is an antitumor agent with weak antibacterial activities that is produced by Streptomyces erythrochromogenes. It was discovered during a search for antitumor agents by screening against the Yoshida sarcoma by Umezawa et al. (1953 b). Sarkomycin was later found to be very effective against Ehrlich ascites carcinoma (Umezawa et al., 1953 a, 1953 b; Okami et al., 1953; Umezawa et al., 1954).

Keywords

Ehrlich Ascites Carcinoma Ehrlich Ascites Tumor Cell Ascites Cell Ehrlich Ascites Carcinoma Cell Ehrlich Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Bickis, I. J., E. H. Creaser, J. H. Quastel, and P. G. Scholefield: Effects of sarcomycin on the metabolism of Ehrlich ascites carcinoma cells. Nature 180, 1109 (1957).PubMedCrossRefGoogle Scholar
  2. Caputo, A., M. Brunori, and R. Giuliano: Antitumoral action of new sarcomycin derivatives. I. Importance of ethyl radical and substituted methylene groups. Cancer Research 21, 1499 (1961a).PubMedGoogle Scholar
  3. Caputo, A., B. Giovanella, and R. Giuliano: Antitumoral action of new sarcomycin derivatives. Nature 190, 819 (1961b)PubMedCrossRefGoogle Scholar
  4. Caputo, A., M. Brunori, and R. Giuliano: Effect of sarcomycin derivatives on solid tumors. Gann 53, 371 (1962).PubMedGoogle Scholar
  5. Caputo, A., M. Brunori, and R. Giuliano: Studies on the action of new sarcomycin derivatives. Acta Unio Intern. contra Cancrum 20, 309 (1964).Google Scholar
  6. Creaser, E. H., and P. G. Scholefield: The influence of dinitrophenol and fatty acids on the P32 metabolism of Ehrlich ascites carcinoma cells. Cancer Research 20, 257 (1960).PubMedGoogle Scholar
  7. Hara, T., Y. Yamada, and E. Akita: Studies on sarkomycin. IV. Preparation of sarkomycin-Inah derivative and stability. II. J. Antibiotics (Japan), Ser. A 10, 62 (1957).Google Scholar
  8. Hooper, I. R., L. C. Cheney, M. J. Cron, O. B. Fardig, D. A. Johnson, D. L. Johnson, F. M. Palermiti, H. Schmitz, and W. B. Wheatley: Studies on sarkomycin. Antibiotics amp; Chemotherapy 5, 585 (1955).Google Scholar
  9. Ishiyama, S.: Clinical observations of some malignant tumors treated with sarkomycin, a new antitumor antibiotic. J. Antibiotics (Japan), Ser. A 7, 82 (1954).Google Scholar
  10. Ishiyama, S., H. Hirayama, M. Takamura, and T. Ohashi: Further observations upon the cytostatic effects of sarkomycin: An experimental study on the Ehrlich ascites carcinoma in mice. J. Antibiotics (Japan), Ser. A 8, 57 (1955).Google Scholar
  11. Keir, H. M., and J. B. Shepherd: Thiol groups in deoxyribonucleic acid nucleotidyltransferase. Biochem. J. 95, 483 (1965).PubMedGoogle Scholar
  12. Kit, S., and J. Awapara: Free amino acid content and transaminase activity of lymphatic tissues and lymphosarcoma. Cancer Research 13, 694 (1953).PubMedGoogle Scholar
  13. Kondo, S.: Sarkomycin [in Japanese]. J. Antibiotics (Japan), Ser. B 16, 210 (1963).Google Scholar
  14. Maeda, K., and S. Kondo: Chemistry on sarkomycin. Chemical studies on antibiotics of Streptomyces. VI. J. Antibiotics (Japan), Ser. A 11, 37 (1958).Google Scholar
  15. Magill, G. B., R. B. Golbey, D. A. Karnofsky, J. H. Burchenal, C. C. Stock, C. P. Rhoads, C. E. Crandall, S. N. Yorukoglu, and A. Gellhorn: Clinical experiences with sarkomycin in neoplastic diseases. Cancer Research 16, 960 (1956).PubMedGoogle Scholar
  16. OBosnI, S., K. Aoki, and T. Sakuraba: Experimental studies on chemotherapy of malignant tumors. II. Influence of sarkomycin on the tumor cells, especially upon the cell division. J. Antibiotics (Japan), Ser. A 8, 153 (1955a).Google Scholar
  17. Oboshi, S., K. Aoki, T. Sakuraba, T. Ishikura, T. Yoshida, M. Sato, and K. Seki: Experimental studies on chemotherapy of malignant tumors. Iii. Inhibitory effects of sarkomycin in a spectrum of ascites tumors in rats and mice. J. Antibiotics (Japan), Ser. A 8, 156 (1955b).Google Scholar
  18. Okami, Y., T. Okuda, T. Takeuchi, K. Nitta, and H. Umezawa: Studies On antitumor substances produced by microorganisms. IV. Sarkomycin-producing Streptomyces and other two Streptomyces producing the anti-tumor substance No. 289 and caryomycin. J. Antibiotics (Japan), Ser. A 6, 153 (1953).Google Scholar
  19. Rabinovitz, M., M. E. Olson, and D. M. Greenberg: Relation of energy processes to the incorporation of amino acids into proteins of the Ehrlich ascites carcinoma. J. Biol. Chem. 213, 1 (1955).PubMedGoogle Scholar
  20. Roberts, E., and P. R. F. Borges: Patterns of free amino acids in growing and regressing tumors. Cancer Research 15, 697 (1955).PubMedGoogle Scholar
  21. Roberts, E., K. Kano Tanaka, T. Tanaka, and D. G. Simonsen: Free amino acids in growing and regressing ascites cell tumors: Host resistance and chemical agents. Cancer Research 16, 970 (1956).PubMedGoogle Scholar
  22. Shrivastava, G. C., and J. H. Quastel: Malignancy and tissue metabolism. Nature 196, 876 (1962).PubMedCrossRefGoogle Scholar
  23. Sugiura, K.: Studies in a tumor spectrum. Viii. The effect of mitomycin C on the growth of a variety of mouse, rat, and hamster tumors. Cancer Research 19, 438 (1959).PubMedGoogle Scholar
  24. Sung, S. C., and J. H. Quastel: Sarcomycin inhibition of deoxyribonucleic acid synthesis in Ehrlich ascites carcinoma cells. Cancer Research. 23, 1549 (1963).PubMedGoogle Scholar
  25. Takeuchi, T.: Bacteriological studies on actinomycetes products exhibiting antitumor activity. II. The bacteriostatic effect of sarkomycin and its relation to sulfhydryl group. J. Antibiotics (Japan), Ser. A 7, 37 (1954).Google Scholar
  26. Takeuchi, T., T. Hikiji, K. Nitta, Y. Morikubo, and H. Umezawa: On antitumor effect of sarkomycin-Inh. J. Antibiotics (Japan), Ser. A 11, 212 (1958).Google Scholar
  27. Takeuchi, T., K. Nitta, T. Hikiji, M. Kinoshita, and H. Umezawa: Antitumor activities of synthetic compounds structurally related to sarkomycin. J. Antibiotics (Japan), Ser. A 14, 54 (1961).Google Scholar
  28. Takeuchi, T., K. Nitta, T. Yamamoto, and H. Umezawa: Effect of sarkomycin on experimental animal tumors. J. Antibiotics (Japan), Ser. A 8, 110 (1955).Google Scholar
  29. Tatsuoka, S., A. Miyake, S. Wada, M. Inoue, E. Iwasaki, and K. Ogata: Studies on sarkomycin. II. Isolation of sarkomycin sulfur compound [in Japanese]. J. Antibiotics (Japan), Ser. B 9, 107 (1956).Google Scholar
  30. Tatsuoka, S., A. Miyake, S. Wada, and E. Iwasaki: Studies on antibiotics. Vii. Structure of S1 and S2 [in Japanese]. J. Antibiotics (Japan), Ser. B 11, 275 (1958).Google Scholar
  31. Toki, K., H. Wada, Y. Suzuki, and C. Saito: Synthesis of sarkomycin. J. Antibiotics (Japan), Ser. A 10, 35 (1957).Google Scholar
  32. Umezawa, S., and M. Kinoshita: Synthesis of 5-methylenecyclopentanone-3-carboxylic acid, an antitumor isomer of sarkomycin. J. Antibiotics (Japan), Ser. A 9, 194 (1956).Google Scholar
  33. Umezawa, H., T. Takeuchi, K. Nitta, Y. Okami, T. Yamamoto, and S. Yamaoka: Studies on anti-tumor substances produced by microorganisms. Iii. On sarko- mycin produced by a strain resembling to Streptomyces erythrochromogene. J. Anti- biotics (Japan), Ser. A 6, 147 (1953a).Google Scholar
  34. Umezawa, H., T. Takeuchi, K. Nitta, T. Yamamoto, and S. Yamaoka: Sarkomycin, an anti-tumor substance produced by Streptomyces. J. Antibiotics (Japan), Ser. A 6, 101 (1953b).Google Scholar
  35. Umezawa, H., T. Yamamoto, T. Takeuchi, T. Osato, Y. Okami, S. Yamaoka, T. Okuda, K. Nitta, K. Yagishita, R. Utahara, and S. Umezawa: Sarkomycin, an anti-cancer substance produced by Streptomyces. Antibiotics amp; Chemotherapy 4, 514 (1954).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1967

Authors and Affiliations

  • Shan-ching Sung

There are no affiliations available

Personalised recommendations